Price movement over the last 24 hours
Archer Aviation Inc vs Canopy Growth Corp — how do they compare? Archer Aviation Inc trades at $4.85 (market cap $3.76B), while Canopy Growth Corp trades at $0.96 (market cap $404.40M). The key difference: Archer Aviation Inc is far larger — about 9.3× Canopy Growth Corp's market cap. Which is the better fit depends on your goals.
| ACHR | CGC | |
|---|---|---|
Market Cap | $3.76B | $404.40M |
Sector | Industrials | Health |
52-Week High | $13.64 | $1.92 |
52-Week Low | $4.68 | $0.86 |
Enterprise Value | $2.11B | $343.85M |
Signals from Pluang's Aura AI — not financial advice
Archer Aviation (ACHR) trades at $5.37, up 7.83% with a bearish technical signal despite recent momentum. The company shows severe financial strain with -$618.2M net income on minimal $300K revenue in 2025, though analyst sentiment remains optimistic with 78% buy ratings. Recent news highlights progress toward FAA certification for its Midnight eVTOL aircraft, with commercialization targeted for 2028 and a $6B order book providing long-term potential.
The stock presents high-risk speculative potential with significant execution hurdles. While regulatory progress and major partnerships with United Airlines and Stellantis support the bullish case, persistent cash burn and negative margins require substantial capital raises. Investors face binary outcomes dependent on successful certification and commercial deployment timelines against intense competition in the emerging eVTOL market.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Archer Aviation develops electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility. Its flagship, Midnight aircraft, is designed for air taxi services, aiming to transform urban travel with sustainable aviation.
Read more on ACHR →Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →